Kamal V. Inamdar, Ed.D.

Affiliations: 
2009 Education Pepperdine University, Malibu, CA, United States 
Area:
Middle School Education
Google:
"Kamal Inamdar"

Parents

Sign in to add mentor
Kamalnayan V. Inamdar grad student 2009 Pepperdine University
 (Factors that inspire preadolescent students to pursue college and career plans.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gomez-Gelvez JC, Salama ME, Perkins SL, et al. (2016) Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy. American Journal of Clinical Pathology
Gulati R, Alkhatib Y, Donthireddy V, et al. (2015) Isolated Ocular Manifestation of Relapsed Chronic Myelogenous Leukemia Presenting as Myeloid Blast Crisis in a Patient on Imatinib Therapy: A Case Report and Review of the Literature. Case Reports in Pathology. 2015: 380451
Gomez-Gelvez JC, Kryvenko ON, Chabot-Richards DS, et al. (2015) Comparative Analysis Reveals Potential Utility of Digital Microscopy in the Evaluation of Peripheral Blood Smears With Some Barriers to Implementation. American Journal of Clinical Pathology. 144: 68-77
Velusamy T, Kiel MJ, Sahasrabuddhe AA, et al. (2014) A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders. Blood. 124: 3768-71
Kanagal-Shamanna R, Lehman NL, O'Donnell JP, et al. (2013) Differential expression of aurora-A kinase in T-cell lymphomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 640-7
Sharma G, Linden MD, Schultz DS, et al. (2010) Cystic tumor of the atrioventricular node: an unexpected finding in an explanted heart. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 19: e75-8
Inamdar KV, Romaguera JE, Drakos E, et al. (2009) Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine. Cancer. 115: 4727-36
Garcia M, Romaguera JE, Inamdar KV, et al. (2009) Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine. Cancer. 115: 1041-8
Inamdar KV, O'Brien S, Sen S, et al. (2008) Aurora-A kinase nuclear expression in chronic lymphocytic leukemia. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 21: 1428-35
Inamdar KV, Medeiros LJ, Jorgensen JL, et al. (2008) Bone marrow involvement by marginal zone B-cell lymphomas of different types. American Journal of Clinical Pathology. 129: 714-22
See more...